AR050260A1 - Derivados de diarilmetilpiperazinas, su preparacion y su utilizacion - Google Patents
Derivados de diarilmetilpiperazinas, su preparacion y su utilizacionInfo
- Publication number
- AR050260A1 AR050260A1 ARP050102998A ARP050102998A AR050260A1 AR 050260 A1 AR050260 A1 AR 050260A1 AR P050102998 A ARP050102998 A AR P050102998A AR P050102998 A ARP050102998 A AR P050102998A AR 050260 A1 AR050260 A1 AR 050260A1
- Authority
- AR
- Argentina
- Prior art keywords
- preparation
- diarilmetilpiperazinas
- derivatives
- diastereomers
- prodrugs
- Prior art date
Links
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 abstract 1
- 208000019901 Anxiety disease Diseases 0.000 abstract 1
- 230000036506 anxiety Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 239000012453 solvate Substances 0.000 abstract 1
- 238000002560 therapeutic procedure Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/155—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pain & Pain Management (AREA)
- Psychology (AREA)
- Rheumatology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE0401968A SE0401968D0 (sv) | 2004-08-02 | 2004-08-02 | Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| US60236304P | 2004-08-18 | 2004-08-18 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR050260A1 true AR050260A1 (es) | 2006-10-11 |
Family
ID=32906880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050102998A AR050260A1 (es) | 2004-08-02 | 2005-07-20 | Derivados de diarilmetilpiperazinas, su preparacion y su utilizacion |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20070249619A1 (enExample) |
| EP (1) | EP1781631B1 (enExample) |
| JP (1) | JP5006785B2 (enExample) |
| CN (1) | CN1993338B (enExample) |
| AR (1) | AR050260A1 (enExample) |
| AT (1) | ATE542806T1 (enExample) |
| AU (1) | AU2005267929B2 (enExample) |
| BR (1) | BRPI0514014A (enExample) |
| CA (1) | CA2576067C (enExample) |
| ES (1) | ES2379364T3 (enExample) |
| NZ (1) | NZ553539A (enExample) |
| PL (1) | PL1781631T3 (enExample) |
| PT (1) | PT1781631E (enExample) |
| RS (1) | RS52315B (enExample) |
| RU (1) | RU2404172C2 (enExample) |
| SE (1) | SE0401968D0 (enExample) |
| SG (1) | SG155181A1 (enExample) |
| SI (1) | SI1781631T1 (enExample) |
| TW (1) | TWI370124B (enExample) |
| UA (1) | UA87146C2 (enExample) |
| WO (1) | WO2006014133A1 (enExample) |
| ZA (1) | ZA200700680B (enExample) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ529401A (en) * | 2001-05-18 | 2005-09-30 | Astrazeneca Ab | 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| SE0203302D0 (sv) * | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| SE0203300D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| SE0203303D0 (sv) | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| DK1781631T3 (da) | 2004-08-02 | 2012-05-14 | Astrazeneca Ab | Diarylmethylpiperazinderivater, præparater dermed og anvendelser deraf |
| SE0401968D0 (sv) * | 2004-08-02 | 2004-08-02 | Astrazeneca Ab | Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| KR101198582B1 (ko) | 2007-12-11 | 2012-11-06 | 에프. 호프만-라 로슈 아게 | 스테아로일-ｃｏａ 불포화화 효소의 억제제 |
| EP2296657A4 (en) * | 2008-05-20 | 2011-12-14 | Astrazeneca Ab | METHOD FOR TREATING HEAVY DEPRESSION WITH FEARING STATES |
| US8314250B2 (en) | 2009-11-24 | 2012-11-20 | Hoffmann-La Roche Inc. | Sultam derivatives |
| US20110207745A1 (en) * | 2009-11-25 | 2011-08-25 | Astrazeneca Ab | Solid forms of 4--n,n-diethylbenzamide, compositions thereof, and uses therewith |
| US9073881B2 (en) | 2011-09-23 | 2015-07-07 | Hoffmann-La Roche Inc. | Benzoic acid derivatives |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH585209A5 (enExample) * | 1973-06-29 | 1977-02-28 | Cermol Sa | |
| US4568649A (en) * | 1983-02-22 | 1986-02-04 | Immunex Corporation | Immediate ligand detection assay |
| SE8500573D0 (sv) * | 1985-02-08 | 1985-02-08 | Ferrosan Ab | Novel piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain |
| US5840896A (en) * | 1989-11-22 | 1998-11-24 | Janssen Pharmaceutica, N.V. | Method of preventing or limiting reperfusion damage |
| GB9202238D0 (en) * | 1992-02-03 | 1992-03-18 | Wellcome Found | Compounds |
| US5681830A (en) * | 1992-02-03 | 1997-10-28 | Delta Pharmaceuticals, Inc. | Opioid compounds |
| US5574159A (en) * | 1992-02-03 | 1996-11-12 | Delta Pharmaceuticals, Inc. | Opioid compounds and methods for making therefor |
| US5807858A (en) * | 1996-06-05 | 1998-09-15 | Delta Pharmaceutical, Inc. | Compositions and methods for reducing respiratory depression |
| DK0711289T3 (da) * | 1993-07-30 | 2000-11-06 | Delta Pharmaceuticals Inc | Piperazinforbindelser til anvendelse i terapi |
| SE9504661D0 (sv) * | 1995-12-22 | 1995-12-22 | Astra Pharma Inc | New compounds |
| SE9904674D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| SE9904673D0 (sv) * | 1999-12-20 | 1999-12-20 | Astra Pharma Inc | Novel compounds |
| SE0001209D0 (sv) * | 2000-04-04 | 2000-04-04 | Astrazeneca Canada Inc | Novel compounds |
| SE0101766D0 (sv) * | 2001-05-18 | 2001-05-18 | Astrazeneca Ab | Novel compounds |
| NZ529401A (en) | 2001-05-18 | 2005-09-30 | Astrazeneca Ab | 4 (phenyl-piperazinyl-methyl) benzamide derivatives and their use for the treatment of pain anxiety or gastrointestinal disorders |
| US7030124B2 (en) * | 2001-10-29 | 2006-04-18 | Ardent Pharmaceuticals, Inc. | Method of treating depression with delta receptor agonist compounds |
| US8476280B2 (en) * | 2002-05-09 | 2013-07-02 | Versi Group, Llc | Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists |
| SE0203303D0 (sv) * | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| SE0203300D0 (sv) * | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| SE0203302D0 (sv) * | 2002-11-07 | 2002-11-07 | Astrazeneca Ab | Novel Compounds |
| SE0400027D0 (sv) * | 2004-01-09 | 2004-01-09 | Astrazeneca Ab | Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
| SE0401968D0 (sv) * | 2004-08-02 | 2004-08-02 | Astrazeneca Ab | Diarylmethyl piperazine derivatives, preparations thereof and uses thereof |
-
2004
- 2004-08-02 SE SE0401968A patent/SE0401968D0/xx unknown
-
2005
- 2005-07-20 AR ARP050102998A patent/AR050260A1/es not_active Application Discontinuation
- 2005-07-21 TW TW094124625A patent/TWI370124B/zh not_active IP Right Cessation
- 2005-07-27 AT AT05762524T patent/ATE542806T1/de active
- 2005-07-27 RS RS20120167A patent/RS52315B/sr unknown
- 2005-07-27 RU RU2007101522/04A patent/RU2404172C2/ru not_active IP Right Cessation
- 2005-07-27 PT PT05762524T patent/PT1781631E/pt unknown
- 2005-07-27 WO PCT/SE2005/001186 patent/WO2006014133A1/en not_active Ceased
- 2005-07-27 JP JP2007524765A patent/JP5006785B2/ja not_active Expired - Fee Related
- 2005-07-27 PL PL05762524T patent/PL1781631T3/pl unknown
- 2005-07-27 AU AU2005267929A patent/AU2005267929B2/en not_active Ceased
- 2005-07-27 NZ NZ553539A patent/NZ553539A/en not_active IP Right Cessation
- 2005-07-27 EP EP05762524A patent/EP1781631B1/en not_active Expired - Lifetime
- 2005-07-27 BR BRPI0514014-5A patent/BRPI0514014A/pt not_active IP Right Cessation
- 2005-07-27 CA CA2576067A patent/CA2576067C/en not_active Expired - Fee Related
- 2005-07-27 US US11/572,948 patent/US20070249619A1/en not_active Abandoned
- 2005-07-27 CN CN2005800262747A patent/CN1993338B/zh not_active Expired - Fee Related
- 2005-07-27 UA UAA200700154A patent/UA87146C2/ru unknown
- 2005-07-27 SI SI200531515T patent/SI1781631T1/sl unknown
- 2005-07-27 ES ES05762524T patent/ES2379364T3/es not_active Expired - Lifetime
- 2005-07-27 SG SG200905179-8A patent/SG155181A1/en unknown
- 2005-10-05 US US11/243,623 patent/US20060030569A1/en not_active Abandoned
-
2007
- 2007-01-24 ZA ZA200700680A patent/ZA200700680B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NZ553539A (en) | 2010-09-30 |
| EP1781631A1 (en) | 2007-05-09 |
| SG155181A1 (en) | 2009-09-30 |
| JP5006785B2 (ja) | 2012-08-22 |
| ES2379364T3 (es) | 2012-04-25 |
| RU2007101522A (ru) | 2008-09-10 |
| TW200612930A (en) | 2006-05-01 |
| US20070249619A1 (en) | 2007-10-25 |
| SE0401968D0 (sv) | 2004-08-02 |
| RU2404172C2 (ru) | 2010-11-20 |
| SI1781631T1 (sl) | 2012-05-31 |
| TWI370124B (en) | 2012-08-11 |
| CN1993338A (zh) | 2007-07-04 |
| WO2006014133A1 (en) | 2006-02-09 |
| AU2005267929B2 (en) | 2010-04-08 |
| EP1781631B1 (en) | 2012-01-25 |
| JP2008508350A (ja) | 2008-03-21 |
| ATE542806T1 (de) | 2012-02-15 |
| US20060030569A1 (en) | 2006-02-09 |
| PT1781631E (pt) | 2012-05-07 |
| AU2005267929A1 (en) | 2006-02-09 |
| CN1993338B (zh) | 2011-07-06 |
| CA2576067C (en) | 2011-05-03 |
| PL1781631T3 (pl) | 2012-07-31 |
| CA2576067A1 (en) | 2006-02-09 |
| BRPI0514014A (pt) | 2008-05-27 |
| ZA200700680B (en) | 2008-09-25 |
| UA87146C2 (ru) | 2009-06-25 |
| RS52315B (sr) | 2012-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP22052564A (es) | Tetrahidrofuranos sustituidos como moduladores de canales de sodio | |
| ECSP034914A (es) | "azaindoles" | |
| ECSP077185A (es) | Derivados de piridina | |
| CR11061A (es) | Derivados de piridina | |
| UY28510A1 (es) | Compuestos quimicos | |
| ECSP045483A (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas útiles como agentes terapéuticos, composiciones farmacéuticas que incluyen a los mismos, y métodos para su uso | |
| AR027437A1 (es) | Derivados de purina | |
| UY30498A1 (es) | Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones | |
| PA8580301A1 (es) | Nuevos derivados de benzoimidazol utiles como agentes antiproliferativos | |
| UY27740A1 (es) | Nuevos compuestos | |
| UY27516A1 (es) | Bencimidazoles | |
| CR9954A (es) | Derivados de pirazina | |
| UY29427A1 (es) | Derivados sustituidos de 2,3,4,5- tetrahidro-1h-pirido (4,3-b) indol, composiciones que los contienen, procesos de preparación y aplicaciones | |
| UY31334A1 (es) | 3a,4,5,6,7,7a-hexahidro-3h-benzoimidazol y derivaods de 3a, 4,5,6,,7,7a-hexahidro-3-indol, enantiómeros, diastereoisómeros, sales farmacéuticamente aceptadas, mezclas, composiciones, preparaciones y aplicaciones de las mismas | |
| AR028624A1 (es) | Heterociclilalquilaminas como antagonistas de receptores muscarinicos | |
| AR045155A1 (es) | Derivados de 6-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos | |
| UY28536A1 (es) | Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos. | |
| AR050260A1 (es) | Derivados de diarilmetilpiperazinas, su preparacion y su utilizacion | |
| AR053554A1 (es) | Derivados de pirimidina para el tratamiento de trastornos hiperproliferativos | |
| AR045156A1 (es) | Derivados de 5-indolilsulfonamidas, su preparacion y su aplicacion como medicamentos | |
| UY29818A1 (es) | Nuevos compuestos de azetidina, composiciones farmaceuticas que los contienen, procesos de preparacion y sus usos terapeuticos | |
| AR044275A1 (es) | Uso de derivados de sulfonamidas para la fabricacion de un medicamento para la profilaxis y/o tratamiento de las disfunciones alimentarias | |
| ECSP066322A (es) | Derivados de 4-indolilsulfonamidas, su preparación y su uso como moduladores de 5-ht-6 | |
| AR025351A1 (es) | Agonistas retinoides selectivos par | |
| UY28715A1 (es) | Derivados de diarilmetil piperazina, sus preparaciones y sus usos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |